Lotte Biologics to Participate in a Series of Global Bio Events in October

[Financial News] Lotte Biologics plans to expand its global contract development and manufacturing organization (CDMO) business by participating in a series of major bio events held in Europe, Asia, and the United States this coming October.
Lotte Biologics announced on the 14th that it will participate in CPHI Milan 2026, held in Milan, Italy, from October 6 to 8; BioJapan 2026 in Yokohama, Japan, from October 7 to 9; and World ADC San Diego in San Diego, U.S., from October 12 to 15.
At CPHI Milan, the company will operate a standalone booth to showcase the large-scale commercial production capabilities of Songdo Bio Campus and the competitiveness of its dual-site operations connecting the U.S. and Korea. Plant 1 of Songdo Bio Campus received approval for use last June.
At BioJapan, the company will highlight its production efficiency and quality-control capabilities, including automated manufacturing management systems (MCS), digital twins, and computational fluid dynamics (CFD) simulations, while holding partnering meetings with potential clients.
In the U.S., the company will participate in World ADC San Diego, a specialized event focused on antibody-drug conjugates (ADCs). Through presentations at the event, it plans to introduce its proprietary ADC platform and CDMO capabilities and expand cooperation with global pharmaceutical and biotech companies.
Lotte Biologics has disclosed four contract wins this year as it expands cooperation with global pharmaceutical and biotech companies. The company plans to continue securing new clients and expanding orders through participation in global events.
A Lotte Biologics official said, "Ahead of becoming GMP-ready, we are focusing on showcasing our large-scale commercial production capabilities and the competitiveness of our Korea-U.S. dual-site operations. We will continue global partnering efforts to expand orders and strengthen our competitiveness."

[email protected] Jeong Sang-hee Reporter